Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop.

Exley MA, Hou R, Shaulov A, Tonti E, Dellabona P, Casorati G, Akbari O, Akman HO, Greenfield EA, Gumperz JE, Boyson JE, Balk SP, Wilson SB.

Eur J Immunol. 2008 Jun;38(6):1756-66. doi: 10.1002/eji.200737389.

2.

The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.

Pyz E, Naidenko O, Miyake S, Yamamura T, Berberich I, Cardell S, Kronenberg M, Herrmann T.

J Immunol. 2006 Jun 15;176(12):7447-55.

3.

Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen.

Sprengers D, Sillé FC, Derkow K, Besra GS, Janssen HL, Schott E, Boes M.

Gastroenterology. 2008 Jun;134(7):2132-43. doi: 10.1053/j.gastro.2008.02.037. Epub 2008 Feb 21.

PMID:
18549881
4.

CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.

Hayworth JL, Mazzuca DM, Maleki Vareki S, Welch I, McCormick JK, Haeryfar SM.

Immunol Cell Biol. 2012 Aug;90(7):699-709. doi: 10.1038/icb.2011.90. Epub 2011 Nov 1.

PMID:
22041925
5.

A cell-type specific CD1d expression program modulates invariant NKT cell development and function.

Zimmer MI, Colmone A, Felio K, Xu H, Ma A, Wang CR.

J Immunol. 2006 Feb 1;176(3):1421-30.

6.

Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.

Wingender G, Berg M, Jüngerkes F, Diehl L, Sullivan BA, Kronenberg M, Limmer A, Knolle PA.

Eur J Immunol. 2006 Mar;36(3):570-82.

7.

Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11.

Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, Rugeles MT, Atkinson MA, Landay AL, Wilson SB.

Immunology. 2007 Sep;122(1):1-14. Epub 2007 Jul 28.

8.

Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.

Capone M, Cantarella D, Schümann J, Naidenko OV, Garavaglia C, Beermann F, Kronenberg M, Dellabona P, MacDonald HR, Casorati G.

J Immunol. 2003 Mar 1;170(5):2390-8.

9.

Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.

Macho Fernandez E, Chang J, Fontaine J, Bialecki E, Rodriguez F, Werkmeister E, Krieger V, Ehret C, Heurtault B, Fournel S, Frisch B, Betbeder D, Faveeuw C, Trottein F.

Int J Pharm. 2012 Feb 14;423(1):45-54. doi: 10.1016/j.ijpharm.2011.04.068. Epub 2011 May 14.

PMID:
21575695
10.

Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.

Denkberg G, Stronge VS, Zahavi E, Pittoni P, Oren R, Shepherd D, Salio M, McCarthy C, Illarionov PA, van der Merwe A, Besra GS, Dellabona P, Casorati G, Cerundolo V, Reiter Y.

Eur J Immunol. 2008 Mar;38(3):829-40. doi: 10.1002/eji.200737518.

11.

Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.

Mallevaey T, Fontaine J, Breuilh L, Paget C, Castro-Keller A, Vendeville C, Capron M, Leite-de-Moraes M, Trottein F, Faveeuw C.

Infect Immun. 2007 May;75(5):2171-80. Epub 2007 Mar 12.

12.
13.

IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2.

Ota T, Takeda K, Akiba H, Hayakawa Y, Ogasawara K, Ikarashi Y, Miyake S, Wakasugi H, Yamamura T, Kronenberg M, Raulet DH, Kinoshita K, Yagita H, Smyth MJ, Okumura K.

Blood. 2005 Jul 1;106(1):184-92. Epub 2005 Mar 3.

14.

A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.

Hameg A, Apostolou I, Leite-De-Moraes M, Gombert JM, Garcia C, Koezuka Y, Bach JF, Herbelin A.

J Immunol. 2000 Nov 1;165(9):4917-26.

16.

Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.

Yang JQ, Wen X, Liu H, Folayan G, Dong X, Zhou M, Van Kaer L, Singh RR.

Arthritis Rheum. 2007 Apr;56(4):1219-33.

17.

Human invariant NKT cells are required for effective in vitro alloresponses.

Patterson S, Kotsianidis I, Almeida A, Politou M, Rahemtulla A, Matthew B, Schmidt RR, Cerundolo V, Roberts IA, Karadimitris A.

J Immunol. 2005 Oct 15;175(8):5087-94.

18.

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V.

J Immunol. 2003 Nov 15;171(10):5140-7.

19.

Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.

Matulis G, Sanderson JP, Lissin NM, Asparuhova MB, Bommineni GR, Schümperli D, Schmidt RR, Villiger PM, Jakobsen BK, Gadola SD.

PLoS Biol. 2010 Jun 22;8(6):e1000402. doi: 10.1371/journal.pbio.1000402.

20.

Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.

Forestier C, Molano A, Im JS, Dutronc Y, Diamond B, Davidson A, Illarionov PA, Besra GS, Porcelli SA.

J Immunol. 2005 Jul 15;175(2):763-70.

Supplemental Content

Support Center